INSUBCONTINENT EXCLUSIVE:
Buying is select heavyweight counters continues to provide oxygen to the benchmark equity indices on Dalal Street
As a result, Nifty50 on Wednesday hit the psychologically important 11,000 mark for the first time since October 2018.
The 15 Nifty
components that have moved higher so far in 2019 include Axis Bank, which has rallied the most at 17 per cent, followed by Reliance
Industries (up 15 per cent), Titan (15 per cent), Infosys (up 15 per cent), Bharti Infratel (up 12 per cent) and Wipro (up 11 per
cent).
Third largest private sector lender Axis Bank recently posted a 131 per cent surge in net income for December quarter at Rs 1,681
crore boosted by a huge jump in recoveries from written-off accounts
Oil-telecom behemoth Reliance Industries reported an 8.8 per cent year-on-year rise in October-December quarter profit at Rs 10,251 crore
per cent drop in December quarter profit on higher expenses even as it approved a Rs 8,260 crore share buyback
Its net profit slumped to Rs 3,610 crore for the quarter from Rs 5,129 crore in the year-ago period, the company said in a statement
Tata Motors, Tech Mahindra, UPL and Kotak Mahindra Bank have gained up to 8.50 per cent so far this year
HCL Technologies last week reported a 19 per cent increase in consolidated net profit at Rs 2,611 crore for December quarter and expressed
confidence in meeting the higher end of its 9.5-11.5 per cent revenue growth guidance for FY2019
Centrum has a hold call on HCL Tech with a target price of Rs 1,125
target price of Rs 2,137.
IT firm Tech Mahindra on February 5 posted a 27.5 per cent increase in consolidated profit after tax (PAT) at Rs
1,203 crore for December quarter
It had reported Rs 9,431 crore PAT for the corresponding period a year ago
CLSA hiked revenue estimates for the IT firm by 1-3 per cent and margin estimates by 75-130 basis points.
Shares of Zee Entertainment and
Indiabulls Housing Finance are down most at 23 per cent and 24 per cent, respectively, during the same period
Among others, shares of Vedanta, MM, Grasim Industries, UltraTech Cement, Adani Ports, Eicher Motors, JSW Steel, HPCL and Hero MotoCorp
have eroded investor wealth by 10 -20 per cent since the beginning of this calendar year
Hero MotoCorp reported a 4.5 per cent drop in its standalone profit after tax (PAT) at Rs 769.1 crore for the third quarter ended December
31 on higher expenses despite selling more vehicles in the period
Till February 5, the Nifty was up 72 points for the year to date from its December 31 close of 10,862.
The guide is here6 Feb, 2019For
investors, the upcoming national elections are a force to reckon with
The Interim Budget has already given its cues.
Market participants are closely tracking the RBI policy trajectory, the first under the new
Governor Shaktikanta Das.
There are other variables at play, too.
So, which stocks can come to your rescue with all these uncertainties
around Edelweiss Securities has stuck its neck out
FY20 looks promising looking at the number of wedding season days
Titan may extend its growth run, led by market share gains, rising share of studded jewellery, new launches and retail expansion
Margin expansion levers such as higher share of studded (jewellery), in-house frame manufacturing (eyewear), cost optimisation and operating
leverage are in place.State Bank of India| Buy| Target price: Rs 356 Feb, 2019Investment rationale: State Bank of India (SBI), after muted
earnings since the past many quarters, posted a respectable PAT in December quarter of Rs 3,950 crore with improved prospects
The company clocked steady improvement in operating metrics and is better positioned to capture emerging opportunities amidst slackened
Further, value in non-banking subsidiaries will be more stable and scalable.? Dabur| Buy| Target price: Rs 5356 Feb, 2019Investment
cent and 10.3 per cent YoY, respectively
The third quarter growth by category is well diversified and well performing categories are making further inroads
Rural growth was 400bps higher than Urban growth
The brokerage expects volume recovery to not only sustain but improve also, aided by the expansion of the herbal market, premiumisation,
innovative launches and a potential uptick in rural spending.? Dr
Domestic business grew 10 per cent YoY on new products launches and is tracking in-line with guidance
The company's promising complex generics pipeline, strong earnings revival and compelling valuations (15.7x FY20E EPS) make it a prime
